Literature DB >> 26586066

Cross-cultural adaptation, validation and reliability of the South Indian (Kannada) version of the Kidney Disease and Quality of Life (KDQOL-36) instrument.

Uday Venkat Mateti, Anantha Naik Nagappa1, Ravindra Prabhu Attur, Shankar Prasad Nagaraju, Shreemathi S Mayya, Rajesh Balkrishnan.   

Abstract

Health-related quality of life is an essential aspect concerned with the treatment outcomes. The main objective of the study is to evaluate the validity and reliability of the South Indian (Kannada) version of the Kidney Disease and Quality of Life-36 (KDQOL-36) instrument for hemodialysis (HD) patients. The KDQOL-36 instrument was validated by the committee of experts consisting of healthcare providers such as nephrologists (three), senior HD staff nurse (one) and clinical pharmacist (one). The measurement properties such as variability, reliability and validity were determined by administering the questionnaire to 82 patients on HD who were randomly selected from the HD units of three hospitals. The test and retest methods were used for reliability. Test-re-test reliability was assessed with a subsample of 45 patients by two administrations of the KDQOL-36 seven days apart. Data were collected through a face-to-face interview. It was evaluated computing intraclass correlation coefficients (ICC) and internal consistency estimated by computing Cronbach's-alfa. Reliability of each Kannada version of the KDQOL-36 sub-scale (symptoms/problems, burden of kidney disease, effects of kidney disease, physical component score [PCS] and mental component score [MCS] was good (Cronbach's-alfa >0.7, ranging from 0.72 to 0.77). The ICC ranged from 0.83 to 0.99 and the 95% confidence interval was 0.76-0.99 for test-retest of the KDQOL-36. The reliability measured with Cronbach's alfa, which was more than 0.72 and ICC ranged from 0.83 to 0.99, indicating that the Kannada version of the KDQOL-36 is reliable and valid for evaluating the health-related quality of life in Kannada-speaking HD patients.

Entities:  

Mesh:

Year:  2015        PMID: 26586066     DOI: 10.4103/1319-2442.168662

Source DB:  PubMed          Journal:  Saudi J Kidney Dis Transpl        ISSN: 1319-2442


  7 in total

Review 1.  Measurement properties of patient-reported outcome measures (PROMs) used in adult patients with chronic kidney disease: A systematic review.

Authors:  Olalekan Lee Aiyegbusi; Derek Kyte; Paul Cockwell; Tom Marshall; Adrian Gheorghe; Thomas Keeley; Anita Slade; Melanie Calvert
Journal:  PLoS One       Date:  2017-06-21       Impact factor: 3.240

2.  Assessment of health-related quality of life and its determinants in patients with chronic kidney disease.

Authors:  M Manavalan; A Majumdar; K T Harichandra Kumar; P S Priyamvada
Journal:  Indian J Nephrol       Date:  2017 Jan-Feb

3.  Effects of Citrate Acid Concentrate on Hemodialysis Adequacy, Reuse, and Quality of Life: A Prospective Randomized Crossover Trial.

Authors:  S P Nagaraju; S Kosuru; R Parthasarathy; A S Mareddy; R P Attur; D Rangaswamy; S Prasad; S Kaza; S Shenoy; K Saraf; S L K Laxminarayana; U V Mateti; V Guddattu
Journal:  Indian J Nephrol       Date:  2018 Jul-Aug

4.  Validation of Kidney Disease Quality of Life Short Form 36 (KDQOL-SF™) in Malayalam among Patients Undergoing Haemodialysis in South Kerala.

Authors:  L Manju; Jigy Joseph; Nazeema Beevi
Journal:  Indian J Nephrol       Date:  2020-02-11

5.  A study of Factors Affecting Dialysis Recovery Time in Haemodialysis Patients in India.

Authors:  Svr Bipin Kumar; B Karthikeyan; Sanjeev Velayudhan Nair; Ashok Ramasamy; Shalman Khan; Soundararajan Periasamy
Journal:  Indian J Nephrol       Date:  2021-01-27

6.  Psychometric properties of the kidney disease quality of life-36 (KDQOL-36) in Ethiopian patients undergoing hemodialysis.

Authors:  Mignote Hailu Gebrie; Hussen Mekonnen Asfaw; Workagegnehu Hailu Bilchut; Helena Lindgren; Lena Wettergren
Journal:  Health Qual Life Outcomes       Date:  2022-02-10       Impact factor: 3.186

Review 7.  Development of a preliminary conceptual model of the patient experience of chronic kidney disease: a targeted literature review and analysis.

Authors:  Jennifer E Flythe; Niklas Karlsson; Anna Sundgren; Paul Cordero; Amanda Grandinetti; Henry Cremisi; Anna Rydén
Journal:  BMC Nephrol       Date:  2021-06-23       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.